Small molecules for perturbing iron homeostasis in bacterial biofilms

扰乱细菌生物膜中铁稳态的小分子

基本信息

  • 批准号:
    10573309
  • 负责人:
  • 金额:
    $ 72.86万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-02-15 至 2027-01-31
  • 项目状态:
    未结题

项目摘要

ABSTRACT Chronic wound care is especially complicated by the formation of bacterial biofilms, commonly by Pseudomonas aeruginosa, Acinetobacter baumannii and Staphylococcus aureus. Biofilms are recalcitrant to antibiotic therapy, which is an important reason why chronic wound infections are so difficult to eradicate. There is a significant need to discover new strategies to combat biofilms. Bacterial iron homeostasis is a suitable novel target for developing anti-infectives because the host makes essential iron scarce to invading pathogens. Bacteria have evolved mechanisms to “steal” iron from their host, but these depend on well-regulated iron homeostasis. To disrupt bacterial iron homeostasis, we are targeting the iron storage protein BfrB and its physiological partner protein, Bfd, which are unique to bacteria. Our work has shown that BfrB regulates cytosolic iron concentrations by (a) oxidizing Fe2+ and storing up to ~3,000 Fe3+ ions in its internal cavity, and (b) forming a complex with Bfd to reduce Fe3+ in the internal cavity of BfrB and release Fe2+ to the cytosol for its incorporation in metabolism. Blocking the BfrB-Bfd complex in P. aeruginosa cells by deletion of the bfd gene perturbs iron homeostasis by triggering an irreversible accumulation of Fe3+ in BfrB and simultaneous cytosolic iron depletion, which leads to impaired biofilm maintenance and biofilm cell death. Our work also led to the discovery of proof-of-concept inhibitors of the BfrB-Bfd complex, which bind BfrB at the Bfd binding site, inhibit iron mobilization, and elicit biofilm cell death. The objectives of this application are to improve the proof-of-concept molecules into lead molecules, evaluate their antibacterial and antibiofilm effectiveness, and evaluate their potential drug suitability. Our interdisciplinary team includes expertise in chemical and structural biology of bacterial iron homeostasis (Rivera), organic synthesis and reaction mechanisms (Bunce), pharmaceutical industry research and development of anti-infectives (Reitz), X-ray crystallography in drug discovery (Lovell), microbial genetics (Chandler), and animal model of infection (Morici). The specific aims are: 1) Evolve proof-of-concept analogs into potent inhibitors of the BfrB-Bfd complex. This work will follow a systematic, iterative strategy of medicinal chemistry synthesis optimization that relies on crystal structures of inhibitor bound BfrB to design each new generation of inhibitors. 2) Asses the antibacterial effectiveness of inhibitors of the BfrB-Bfd complex and evaluate their potential drug suitability.
摘要 慢性伤口护理特别复杂的细菌生物膜的形成,通常由假单胞菌 铜绿假单胞菌、鲍曼不动杆菌和金黄色葡萄球菌。生物膜对抗生素治疗是无效的, 这是慢性伤口感染如此难以根除的重要原因。存在显著 我们需要找到对抗生物膜的新策略。细菌铁稳态是一个合适的新靶点, 开发抗感染药物,因为宿主使必需的铁缺乏入侵病原体。细菌已经 它们进化出了从宿主体内“窃取”铁的机制,但这些机制依赖于调节良好的铁体内平衡。到 破坏细菌铁稳态,我们针对铁储存蛋白BfrB及其生理伴侣 蛋白质,Bfd,这是细菌特有的。我们的工作表明,BfrB调节胞浆铁浓度 通过(a)氧化Fe 2+并在其内腔中储存高达约3,000个Fe 3+离子,以及(B)与Bfd形成络合物 还原BfrB内腔的Fe ~(3+),并将Fe ~(2+)释放到胞质溶胶中,使其参与代谢。 通过缺失bfd基因阻断铜绿假单胞菌细胞中的BfrB-Bfd复合物, 引发BfrB中Fe 3+的不可逆积累和同时的胞质铁耗竭,这导致 受损的生物膜维持和生物膜细胞死亡。我们的工作还导致了概念验证的发现 BfrB-Bfd复合物的抑制剂,其在Bfd结合位点结合BfrB,抑制铁动员,并引起铁结合。 生物膜细胞死亡。本申请的目的是将概念验证分子改进为铅 分子,评估它们的抗菌和抗菌膜的有效性,并评估它们潜在的药物适用性。 我们的跨学科团队包括细菌铁稳态的化学和结构生物学专业知识 (里维拉)、有机合成和反应机理(邦斯)、制药工业研究和 抗感染药物的开发(雷茨),药物发现中的X射线晶体学(洛弗尔),微生物遗传学 (钱德勒)和感染动物模型(Morici)。具体目标是:1)发展概念验证类似物 BfrB-Bfd复合物的有效抑制剂。这项工作将遵循一个系统的,迭代的战略, 化学合成优化依赖于抑制剂结合BfrB的晶体结构来设计每个新的 抑制剂的产生。2)评估BfrB-Bfd复合物抑制剂的抗菌效果, 评估其潜在的药物适用性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mario Rivera其他文献

Mario Rivera的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mario Rivera', 18)}}的其他基金

Chemical tools for perturbing iron homeostasis in P. aeruginosa
扰乱铜绿假单胞菌铁稳态的化学工具
  • 批准号:
    9158507
  • 财政年份:
    2016
  • 资助金额:
    $ 72.86万
  • 项目类别:
Chemical tools for perturbing iron homeostasis in P. aeruginosa
扰乱铜绿假单胞菌铁稳态的化学工具
  • 批准号:
    9674978
  • 财政年份:
    2016
  • 资助金额:
    $ 72.86万
  • 项目类别:
DYNAMICS & INTERPROTEIN INTERACTIONS IN RELEASE OF IRON IN BACTERIOFERRITIN
动力学
  • 批准号:
    8359665
  • 财政年份:
    2011
  • 资助金额:
    $ 72.86万
  • 项目类别:
MECHANISM OF HEME CAPTURE BY THE HEMOPHORE SECRETED BY PSEUDOMONAS AERUGINOSA
铜绿假单胞菌分泌的血红素捕获血红素的机制
  • 批准号:
    7959522
  • 财政年份:
    2009
  • 资助金额:
    $ 72.86万
  • 项目类别:
CYTOCHROME B5--A CASE STUDY IN MOLECULAR RECOGNITION
细胞色素 B5——分子识别案例研究
  • 批准号:
    2188376
  • 财政年份:
    1995
  • 资助金额:
    $ 72.86万
  • 项目类别:
CYTOCHROME B5--A CASE STUDY IN MOLECULAR RECOGNITION
细胞色素 B5——分子识别案例研究
  • 批准号:
    2685028
  • 财政年份:
    1995
  • 资助金额:
    $ 72.86万
  • 项目类别:
Structure, Function and Dynamics of Heme Degrading Enzymes
血红素降解酶的结构、功能和动力学
  • 批准号:
    7199450
  • 财政年份:
    1995
  • 资助金额:
    $ 72.86万
  • 项目类别:
Structure, Function and Dynamics of Heme Degrading Enzymes
血红素降解酶的结构、功能和动力学
  • 批准号:
    7286752
  • 财政年份:
    1995
  • 资助金额:
    $ 72.86万
  • 项目类别:
Cytochrome b5--A Case Study in Molecular Recognition
细胞色素b5——分子识别案例研究
  • 批准号:
    6606890
  • 财政年份:
    1995
  • 资助金额:
    $ 72.86万
  • 项目类别:
CYTOCHROME B5--A CASE STUDY IN MOLECULAR RECOGNITION
细胞色素 B5——分子识别案例研究
  • 批准号:
    2392193
  • 财政年份:
    1995
  • 资助金额:
    $ 72.86万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 72.86万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 72.86万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 72.86万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 72.86万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 72.86万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 72.86万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 72.86万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 72.86万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 72.86万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 72.86万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了